(3)EMD Serono Research & Development Institute Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: (3)EMD Serono Research & Development Institute

Poster-Non-imaging Biomarkers

October 25, 2021

Concentration of Evobrutinib, a Brutons Tyrosine Kinase Inhibitor, in Cerebrospinal Fluid during Treatment of Patients with Relapsing Multiple Sclerosis in a Phase 2 Study

Background: Evobrutinib, a highly selective Brutons tyrosine kinase (BTK) inhibitor, demonstrated a low annualized relapse rate (75mg...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC